All Articles

A deep dive into the 'NO CAP' campaign reveals how AI-driven cultural targeting and questionable metrics are defining the new frontier of political advocacy.

Phanes Therapeutics has advanced its first-in-class bispecific antibody into colorectal cancer trials, testing a novel mechanism to bypass systemic toxicity.

As a weak yen makes Western universities too expensive, Japanese families are turning to Malaysia for high-value, English-medium tertiary education.

Builders are pouring millions into AI to fix labor shortages and project delays. But as legal risks mount, the true return on investment remains a mystery.

Luca Mining secures C$211M to acquire Capstone's Cozamin mine, backed by heavyweights. Here is the strategy driving this transformative copper-silver play.

CMS approval for B. Braun's Stimuplex needles under the NOPAIN Act signals a major shift in how outpatient centers fund opioid-sparing pain management.

The historic Molson brewery site is transforming into a sustainable waterfront district, testing Montreal’s new housing and climate policies on a massive scale.

Williams-Sonoma leverages influencer equity and heritage luxury to fuel its e-commerce engine and loyalty ecosystem in its latest exclusive home decor launch.

Kraft Heinz is challenging a century of canned soup dominance by launching a premium, ready-to-eat pouch collection exclusively in the Canadian market.

As rivals flood their platforms with synthetic content, Storyblocks is betting its 10-million asset library on human authenticity and legal indemnification.

By linking complex scheduling data with daily site execution, Kahua's new enterprise tool aims to solve the persistent problem of construction budget blowouts.

Centinel Spine just secured FDA two-level approval for its prodisc C Nova. Here is why tri-implant optionality is the end of one-size-fits-all spinal fusion.

SecTor 2026 exposed a critical shift in cybersecurity, highlighting the commercial gaps in threat intelligence and the governance risks of agentic AI.

Pilatus Biosciences doses its first Hong Kong patient with PLT012, signaling a strategic shift toward metabolic immunotherapies and Asian clinical hubs.

As AI drives a massive data center bottleneck, Daikin Applied's expanded modular factory shifts HVAC from construction sites to the assembly line.

As mutual fund outflows persist, traditional active managers are aggressively pivoting to custom models, active ETFs, and independent wealth channels.

Don Weinstein’s appointment to CoAd’s board signals a major private equity play to transform the PEO market with autonomous AI and agentic workflows.

HighLevel's appointment of Grubhub founder Matt Maloney to its board signals a strategic maturation as the $1 billion AI platform eyes enterprise-grade scale.

BrowserStack’s new load testing platform exposes a critical blind spot in Q4 readiness: your servers might be fine, but your customers' browsers are crashing.

By halving infusion volumes for immunodeficiency patients, Takeda's experimental TAK-881 is not just treating a disease—it is giving people their time back.